Novel HIV-1 therapeutics through targeting altered host cell pathways. - Wikidata - awgldk - TriplyDB

Novel HIV-1 therapeutics through targeting altered host cell pathways.

Novel HIV-1 therapeutics through targeting altered host cell pathways.

http://www.wikidata.org/entity/Q37445903

about

The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways Structural insights of non-canonical U*U pair and Hoogsteen interaction probed with Se atom Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.Transcriptome Analysis Reveals Novel Entry Mechanisms and a Central Role of SRC in Host Defense during High Multiplicity Mycobacterial Infection HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation Cellular networks involved in the influenza virus life cycle.The human transcriptome during nontyphoid Salmonella and HIV coinfection reveals attenuated NFkappaB-mediated inflammation and persistent cell cycle disruption.Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.Host cell factors as antiviral targets in arenavirus infection.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.HIV-1 replication and latency are regulated by translational control of cyclin T1 Targeting HIV transcription: the quest for a functional cure.Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activity.Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors.Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications.Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity.Research highlights on a notable retrovirus and a popular guardian gene.Cyclin E goes nuts: a cell cycle regulator affects male fertility.

P2860

Q27027607-1B7A958F-DB80-4AC2-8E7D-A430314C2085 Q27679886-5C3B45C5-84D0-4FF3-8386-50007835B86D Q28483731-297A3152-9150-4A45-BC23-621C7501E8AB Q28552171-1B77EBD4-1512-4707-8F0E-68848D54F058 Q33626049-196A81F6-CE7B-4A84-A550-E6807AC54F90 Q34793396-239003FB-EB93-4C36-9CF5-9F34092FA204 Q34990993-3D623897-428E-4A1A-9D9C-285550FF22AF Q35077455-50776600-6967-4735-B47F-2845924BC854 Q35196542-0A68AD63-7B7A-4504-A303-D71A81F524C9 Q35214153-5F6FF08D-B7AD-445F-9FCE-77C888F9672C Q36872701-71C748CB-6990-4659-8394-C3B35D94E893 Q37812614-0348371F-A9A4-4308-8B50-47CB9E00FC6E Q38061425-D7C5EA68-8A02-416F-A5C3-6D89B829C3BF Q38212101-51F07BD8-C10E-4ECE-8B9B-5F8F92E04F88 Q38273477-BC333FA1-D191-42EB-A26F-7823A72007A5 Q38366762-A8B78799-88EF-410A-91E7-E1182A9AD2E4 Q39073158-95E77E71-BFC0-467B-A4A9-833F4C44ABF2 Q39378609-B25284EB-F62C-4B75-B4CB-9F3F97F4ACB9 Q39419450-D3ED9F11-8856-4A92-B78E-4E3FB29F3A02 Q39543548-48F8035F-1648-4ED2-9695-1AA318AC71C0 Q43006056-EE61ADA6-522E-4516-AA6D-D496CFEBDECD Q53273895-BD2C597B-EC52-495A-B2F3-2C8052F7DF95

P2860

Novel HIV-1 therapeutics through targeting altered host cell pathways.

http://www.wikidata.org/entity/Q37445903

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@en

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@nl

type

label

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@en

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@nl

prefLabel

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@en

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@nl

P1433

Q37445903-682A8980-1FDD-4A0F-B43F-D3B903B7772C

P1476

Q37445903-A4756E85-CF19-4649-93BD-ECBD7964BEBA

P2093

Q37445903-097014E0-4A85-4E80-86DE-452D1D8EAC73

Q37445903-D89B7A90-5D43-4C39-A233-F9ADB9597E77

Q37445903-F5EC6D03-3CFA-4F95-8C97-1D71333B7C71

P2860

Q37445903-02AB9056-6EEE-498D-9350-36C8F0BF221E

Q37445903-0384AE0B-4FFD-41AF-B805-4BA4D1BA4E4C

Q37445903-041E6854-3911-43B5-A514-5CEA2D7BE232

Q37445903-054C0DCB-08CA-486B-8D2C-EB2A7AC6865C

Q37445903-0604007B-1B7F-493F-B897-C6B0B5CF15A3

Q37445903-06BD713D-0D19-4064-A2F5-ADC734F16D18

Q37445903-078963D9-03CE-4ED6-9A44-8065BCFFD42E

Q37445903-079BB2EC-6B23-4147-A5F6-FF9ED4F3A999

Q37445903-0922A0F6-C135-4763-8BB1-45D62BA68062

Q37445903-09E494C4-5B66-4573-974D-A056D4D1CA7F

P304

Q37445903-DF169CB4-4F40-497F-9E03-433178D9E5EA

P31

Q37445903-44630FC5-CE48-4C52-86CE-994814F46D6A

P356

Q37445903-A5462B17-3331-4561-968C-965FCC898E7D

P407

Q37445903-077F4968-B626-4A20-BC01-910E1319EF21

P433

Q37445903-2391A113-CEB6-442F-8CAF-7B98EC231F06

P478

Q37445903-70E48ACE-6104-4780-8A2D-13762F457CC3

P50

Q37445903-49789FE6-7D60-4BF2-9A8F-6D95E7CB3067

P577

Q37445903-D0302E60-6AAD-4145-B56E-440BE1E2A1FA

P5875

Q37445903-5B58EAF2-599D-4BAE-97B1-424042369D75

P698

Q37445903-0B90CB17-D951-4132-9AE9-94DC9C3405B8

P921

Q37445903-211B5AF2-5E7D-4D5E-8685-3A54A5B33CDB

P932

Q37445903-634E41C3-C9D7-4AED-9037-D684F8A832A1

P356

14712590903257781

P1433

Expert Opinion on Biological Therapy

P1476

Novel HIV-1 therapeutics through targeting altered host cell pathways.

@en

P2093

Fatah Kashanchi

http://www.w3.org/2001/XMLSchema#string

Rachel Van Duyne

http://www.w3.org/2001/XMLSchema#string

William Coley

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression

Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element

Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21WAF1

Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA

Identification of host proteins required for HIV infection through a functional genomic screen

Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

New functional activities for the p21 family of CDK inhibitors

Cell cycle, CDKs and cancer: a changing paradigm

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

P304

1369-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712590903257781

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Kylene Kehn-Hall

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26791133

http://www.w3.org/2001/XMLSchema#string

P698

19732026

http://www.w3.org/2001/XMLSchema#string

P921

P932

2785118

http://www.w3.org/2001/XMLSchema#string